Purpose To perform a systematic review and meta-analysis of the literature inherent robotic nephroureterectomy (RNU) and to compare its outcomes with those of other nephroureterectomy (NU) techniques. Methods A systematic literature search was performed up to April 2019 using PubMed, Embase®, and Web of Science. The Preferred Reporting Items for Systematic Review and Meta-analysis Statement was followed for study selection. The following data were extracted for each study: baseline features, surgical outcomes, oncological outcomes, and survival outcomes. Stata® 15.0 was used for statistical analysis. Results Literature search identified 80 studies eligible for the meta-analysis and overall 87,291 patients were included in the analysis: open NU (ONU; n = 45,601), hand-assisted laparoscopic NU (HALNU; n = 442), laparoscopic NU (LNU n = 31,093), and RNU (n = 10,155). RNU was more likely to be performed in those patients with multifocal tumor location (proportion: 0.19; 95% CI 0.14, 0.24) and high-grade disease (proportion: 0.70; 95% CI 0.53, 0.68). The lowest EBL was recorded in the RNU group (weighted mean (WM) 163.31 mL; 95% CI 88.94, 237.68), whereas the highest was in the ONU group (414.99 mL; 95% CI 378.52, 451.46). Operative time was shorter for ONU (224.98 mL; 95% CI 212.26, 237.69). RNU had lower rate of intraoperative complications (0.02; 95% CI 0.01, 0.05). ONU showed higher odds of transfusions (0.20; 95% CI 0.15, 0.25). LOS was statistically significantly shorter for the RNU group (5.35 days; 95% CI 4.97, 5.82). HALNU seemed to present lower risk of PSM (0.02; 95% CI − 0.01, 0.05), and lower risk of recurrence (0.22; 95% CI 0.15, 0.30), metastasis (0.07; 95% CI 0.05, 0.10), and cancer-related death (0.03; 95% CI 0.01, 0.06). ONU showed the lowest 5 years cancer specific survival (proportion: 0.77; 95% CI 0.74, 0.80). No correlation was found between the surgical technique and recurrence-free and cancer-specific survival. Conclusions Evidence regarding RNU for the treatment of UTUC is increasing but it remains quite sparse and of low quality. Despite this, RNU seems to be safe, and to offer the advantages of a minimally invasive approach without impairing the oncological outcomes. Nevertheless, ONU, HALNU, and LNU still represent a valid, and commonly used surgical treatment option. As RNU becomes more popular, and concerns related to its use remain, the best surgical technique for NU remains to be determined.
Introduction
Current guidelines recommend radical nephroureterectomy (NU) with bladder cuff excision (BCE) as the standard treatment for high-risk upper tract urothelial carcinoma (UTUC) [1] . The last two decades witnessed the introduction and diffusion of minimally invasive surgery techniques for NU [2] . Laparoscopic NU (LNU) showed to offer lower surgical Electronic supplementary material The online version of this article (https ://doi.org/10.1007/s0034 5-019-03020 -1) contains supplementary material, which is available to authorized users.
* Riccardo Autorino ricautor@gmail.com Extended author information available on the last page of the article morbidity and shorter length of hospital stay, despite controversial findings about its oncological safety [3] . Equally, robotic NU (RNU) has been explored and increasingly implemented as robotic technology can facilitate key steps of the NU procedure, such as BCE and lymphadenectomy [3, 4] . However, current literature still lacks robust evidence regarding RNU outcomes, as available data are mostly from small series or population-based studies [5] [6] [7] . Aim of this study is to perform a systematic review and meta-analysis of the literature inherent RNU and to compare its outcomes with those of other NU techniques, including open NU (ONU), hand-assisted laparoscopic nephroureterectomy (HALNU) and LNU.
Methods

Literature research strategy
Two different authors (A.V. and S.F.) independently screened literature regarding ONU, HALNU, LNU, and RNU. The results were assessed by a third author (R.A.). PubMed, Embase®, and Web of Science were queried up to April 2019. A free-text strategy was deemed to be the most suitable for this topic (as summarized in supplementary material 1). Comparative and non-comparative retrospective, prospective, non-and randomized studies were included.
Non-English language articles, conference abstract, conference paper, reviews, letters, notes, editorials, and book chapters and studies published before 2000 were excluded. Possible missing articles were retrieved by the assessment of the reference list of each article included.
Studies selection
The Preferred Reporting Items for Systematic Review and Meta-analysis Statement (PRISMA Statement-www.prism a-state ment.org) [8, 9] was followed for study selection. Eligible studies were identified based on the following inclusion criteria: studies on minimally invasive NU, in adult population (patients older than 18 years old), and for diagnosis of UTUC. Given the very limited number of studies, it was established to not include in the analysis data about laparoendoscopic single site NU (LESS-NU), and laparoendoscopic single site robotic nephroureterectomy (LESS-RNU). After a first screening based on title and abstract, full texts of potentially eligible studies were evaluated, and those meeting inclusion criteria were selected.
Data extraction
The following data were extracted for each study: -baseline features: age, gender (♂), body mass index (BMI), race (Caucasian), Charlson Comorbidity Index (CCI) ≥ 2, American Society of Anesthesiologist (ASA) score ≥ 3, tumor location (pelvicalyceal, ureteral, multifocal), and surgery performed in an academic hospital; -surgical outcomes: estimated blood loss (EBL), operative time (OT), intraoperative complications, transfusions, overall complications, major complications (Clavien ≥ 3), and length of stay; -pathological outcomes: pT ≥ 3, high-grade tumor, pN + , nodes removed, and positive surgical margins (PSM); -survival outcomes: recurrence, metastasis, death, 2-and 5-years recurrence free survival (RFS), 2-and 5-years cancer specific survival (CSS), and correlation between surgical technique and RFS and CSS.
Study quality assessment
Level of Evidence (LE) of the studies was established according to the Oxford Level of Evidence Working Group 2011 [10] . The quality of the reports was stratified conforming to the Newcastle-Ottawa Assessment Scale (NOS) for non-randomized controlled trials [11] . A score of 5 was considered low, 6-7 intermediate, and 8-9 high. Jadad Scale was adopted as evaluation mean for randomized controlled trials (RCT's) [12] . A score of 2 or less identified lowquality studies, 3 intermediate quality reports, and 4-5 high quality RCT.
Data analysis
Data were collected into separate datasheets per each outcome assessed. Variables reported as median (range) were converted to mean ± standard deviation (SD) through a dedicated formula [13] . Grand mean was calculated for those data inherent the same variable but split in two groups. Mean ± SD were transformed into mean (95% confidence interval) (CI). It was performed pooled analysis of mean (95% CI) for continuous values using the metan function.
For dichotomous values, cumulative analysis of proportion was performed using the metaprop function. Regarding survival outcomes, log of Hazard Ratios (HR) and 95% CI were generated to pool the data. Heterogeneity among the studies was weighted according to random effect [14] . Funnel plots were evaluated to establish the presence of publication bias. We also performed a sensitivity analysis of survival out- 
Results
Studies features
The PRISMA flow chart is showed in Fig. 1 . The literature search identified 80 studies eligible for the metaanalysis (supplementary table 1 ). Over the last decade, there has been an increase in number of studies on RNU (from 0% of studies in 2000-2009 to 36% in the period 2010-2019) (supplementary Fig. 1 ). Two studies were prospective LE 2 [4, 14] , and one RCT LE 1 [35] . The remaining studies were all retrospective of LE 3. Twenty reports were of high quality [ 
Baseline features
RNU was more likely to be performed in those patients with multifocal tumor location (proportion: 0.19; 95% CI 0.14, 0.24). There was no statistically significant difference among the surgical techniques regarding other baseline parameters (supplementary material 2). 
Pathological outcomes
RNU was performed more in those patients with high-grade pathology (proportion: 0.70; 95% CI 0.53, 0.68), while we did not find any statistically significant difference between ONU, HALNU, and LNU (50%, 57%, and 50% probability, respectively). There was no statistically significant difference among the procedures regarding pN + , as well as of lymph nodes removed too. HALN presented the lowest risk of PSM (proportion: 0.02; 95% CI − 0.01, 0.05) (supplementary material 2).
Survival outcomes
Overall, HALNU showed the lowest risk of recurrence (proportion: 0.22; 95% CI 0.15, 0.30), metastasis (proportion: 0.07; 95% CI 0.05, 0.10), and cancer-related death (proportion: 0.03; 95% CI 0.01, 0.06). ONU showed the lowest 5-year cancer specific survival (CSS) (proportion: 0.77; 95% CI 0.74, 0.80), whereas there was no statistically significant difference among HALNU, LNU, and RNU in terms of 2-and 5-year recurrence free survival (RFS) and cancer specific survival (CSS) (supplementary material 2). We did not find correlation between the surgical technique (ONU vs LNU vs RNU) and RFS and CSS, but only one study assessed these parameters for RNU [79] (Fig. 2 and supplementary material 2).
Sensitivity analysis of survival outcomes of open vs intracorporeal BCE
Intracorporeal BCE showed lower rate of bladder recurrence (proportion: 0.18; 95% CI 0.12, 0.24 vs proportion: 0.27; 95% CI 0.20, 0.33). Despite patients with intracorporeal BCE being more likely to develop postoperative metastasis, the difference with the open BCE group was not statistically significant (18% vs 12%; p = 0.059). Moreover, no statistically significant difference was found in terms of recurrence and death ( Fig. 3 ).
Bias assessment
The evaluation of the funnel plots of each outcome demonstrated a quite diffused presence of bias among the studies included (supplementary Fig. 2 ).
Discussion
To the best of our knowledge, herein we present the data of the largest systematic review and meta-analysis on NU to date, including 80 studies and a cohort of about 87,000 patients. Our analysis raises some points which are worth discussing.
Patients showed no statistically significant difference in terms of baseline features, and there was a prevalence of Caucasian male subjects with a mean age of 67.6 years. These figures mirror those from well-known epidemiological data about UTUC [15] . Less forecasted was the higher proportion of multifocal tumor in the RNU group compared to the others (19% vs overall 10%). Nevertheless, none of the Regarding surgical outcomes, RNU showed the lowest EBL compared to other surgical procedures. This finding is consistent with a recent report assessing a cohort of 422 patients who underwent ONU, LNU, and RNU, demonstrating lower EBL for the robotic group [16] . Lower EBL translated into a lower transfusion rate, whereas ONU showed higher odds of transfusions (20%) [17] . LNU also had higher transfusion rate, but it was not clinically significant compared to RNU (11% vs 9%). A previous study comparing RNU and LNU demonstrated a more significant difference (8% and 30%, respectively) [18] .
Differently from the other reports on this topic, RNU showed no statistically significant difference in OT compared to the other procedures. Melquist et al. evaluated LNU and RNU and the latter demonstrated a longer OT [18] . In addition, in our series ONU registered the shortest OT. Despite this, the difference with the robotic one was of only 26 min which could be a consequence of the robot docking or repositioning during the procedure. In fact, a recent comparative study on RNU performed with Xi platform demonstrated OT to be shorter of about 50 min [19] , as the advantage of this new platform is to smoothly perform the entire procedures without need for re-docking or patient repositioning [20] . Unfortunately, there were no other studies available to perform a sensitivity analysis on this point. RNU demonstrated a slightly lower rate of intraoperative complications (2% vs overall 4%). A reasonable explanation might reside in the advantages provided by the robotic surgery such as better vision, and instruments precision, maneuverability and delicacy in applying traction on the tissues [6] . On the other hand, overall-and major complications were overlapping between RNU and the other ones. A population-based study evaluated the complications rate among ONU, LNU, and RNU within a population of about 20,000 patients and found no-difference in terms of 90-day mortality and complications [21] . Notwithstanding this, in our cohort RNU showed a smaller, better clinical trend of complications with a 17% vs 20% of the ONU and LNU. Though complications were overlapping, RNU had a significantly shorter LOS. This data mirrored those from previous studies [16] . Indeed, Trudeadu et al. conducted a propensity score matched paired analysis between LNU and RNU within the Nationwide Impatient Sample database. The authors concluded that there was no-difference regarding LOS among the two procedures [22] . Notably, our results pointed out shorter LOS for RNU compared to LNU too. This could be explained with the increase of the expertise and diffusion of the robotic procedure which drastically improved the outcomes. Lee et al. found that after the first 42 robotic procedures there was a reduction of EBL, LOS, and analgesic usage [16] . However, differences in practice patterns in different countries could also account for this finding, as in the US, where most robotic series come from, there is a general trend to discharge home earlier compared to European and Asian countries.
The assessment of pathological outcomes proved no statistically significant difference among all the procedures about the pathological stage (pT ≥ 3 and N + ), while patients with high-grade tumor were more likely to undergo RNU. This finding seems to reflect more on a general trend in favor of RNU during the last decade than a specific choice of robotic surgery for this subset of patients. Several studies underlined this point highlighting the dissemination of robotics and the decrease of the ONU and LNU [21, 23] .
In our study, RNU showed to yield higher number of nodes with about 11 nodes removed per procedure against 7 of ONU and LNU, and 5 of HALNU. Zargar et al. in one of the first experience on RNU already demonstrated the advantages of robotics during lymph node dissection reporting a mean value of 9.4 harvested nodes [24] . Compared to ours, also Moschini et al. achieved a similar value of nodes resected during ONU and LNU [25] . Nevertheless, the number of lymph nodes yielded was reported in a low number of studies with a high heterogeneity among the studies (I 2 = 99%). Thus, this data should be interpreted with caution considering the several bias which might have affected this finding such as selection bias, different experience, and hospital volume.
A lower incidence of recurrence, metastasis, and cancerrelated death was found for HALNU, and these findings were consistent for most studies on HALNU. On the other hand, ONU, LNU, and RNU studies were characterized by some degree of heterogeneity. Two-year RFS and CSS were overlapping among all the procedures, while we found a lower 5-year CSS in the ONU group. This data was different from previous literature. Indeed, Nouralizadeh et al. performed a literature review on ONU, HALNU, and LNU, and none of the procedures showed to overcome the others regarding survival outcomes [26] . This inconsistency might be a consequence of the larger number of studies and sample size of our analysis (80 vs 52 studies and 87,291 vs 19,195 patients) . In addition, our meta-analysis is the first to include RNU which could have influenced the results of the overall cumulative analysis.
One of the main concerns regarding minimally invasive NU is the risk of recurrence and tumor seeding, including bladder recurrence [27, 28] . A recent meta-analysis on the comparison between ONU and LNU suggested poorer outcomes for the latter [29] . Simone et al. achieved the same results in the only RCT available, but the sample size did not allow to generalize its findings [30] . Our sensitivity analysis showed no statistically significant difference among open and intracorporeal BCE in terms of recurrence, and death, but this was not the case regarding bladder recurrence. In fact, we found lower rate of bladder recurrence in the intracorporeal BCE group. Most of the data regarding intracorporeal BCE come from studies assessing RNU and the lower rate of bladder recurrence could be due to the advantages of the robotic to manage the distal ureter [6] . Of note, most of the studies included mixed techniques to approach bladder cuff, so fewer studies addressed specifically a BCE management. Thus, a low number of studies could be pooled explaining the fickle approach to BCE.
To note, it was not possible to account for those patients who underwent adjuvant bladder instillation after the procedure, even though recent evidence suggests no advantage in terms of survival outcomes [31] . On the contrary, we found higher risk of metastasis in the intracorporeal group, which however could be related to the fact that the RNU group presented more multifocal and higher-grade disease. Nevertheless, this finding should be further scrutinized.
This meta-analysis is supported by its adequate and rigorous methodological approach, and the large sample size. Notwithstanding these, our study presents some intrinsic limitations that should be disclosed. This is a meta-analysis of retrospective and non-randomized studies which are affected by several bias which cannot be avoided. The retrospective nature of the studies includes selection, attrition, reporting and other bias which might have influenced the results. Indeed, it was not possible to establish the blinding of participants or personnel, the blinding of outcomes assessment, and in some cases incomplete outcomes assessment was noticed. Nevertheless, the inclusion of prospective and RCTs could have balanced our findings. Second, most of the reports are based on data of NUs performed with several techniques of BCE, whose oncological impact remains unclear. Unfortunately, we could not perform a specific analysis for the myriad of BCE techniques, such as pluck technique, ureter stripping, transurethral resection, or intussusception. Third, the different studies were from different institutions and set in different countries, so the nonclinical factors might have had an impact on outcomes. This could also be in-part responsible of the high heterogeneity registered for most of the studies included. Fourth, the study distribution is unbalanced in favor of ONU, and LNU, so the data on the other techniques might be weak. Fifth, this analysis includes comparative and non-comparative studies. Comparative studies are related to similar conditions among the arms and this could have influenced the results in favor of one arm rather than another. For this reason our results should be interpreted cautiously. Last, the sample size of most of the studies is small, thus they might be underpowered to evaluate the outcomes assessed. Furthermore, the large sample size reports are few and in many cases population-based. Another limitation that should be acknowledged is the low number of studies about RNU. Given these facts, our data should be interpreted by taking these limitations into account. Moreover, our analysis did not consider other kidney sparing procedures for the management of UTUC [32] .
Conclusions
Evidence regarding RNU for the treatment of UTUC is increasing but it remains quite sparse and of low quality. Despite this, RNU seems to be safe, and to offer the advantages of a minimally invasive approach without impairing the oncological outcomes. Nevertheless, ONU, HALNU, and LNU still represent a valid, and commonly used surgical treatment option. As RNU becomes more popular, and concerns related to its use remain, the best surgical technique for NU remains to be determined. Future clinical research should ideally aim at prospective randomized studies, possible on multicenter scale.
